BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37792550)

  • 21. STAT3- and GSK3β-mediated Mcl-1 regulation modulates TPF resistance in oral squamous cell carcinoma.
    Maji S; Shriwas O; Samal SK; Priyadarshini M; Rath R; Panda S; Das Majumdar SK; Muduly DK; Dash R
    Carcinogenesis; 2019 Mar; 40(1):173-183. PubMed ID: 30395230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exosome-mediated long noncoding RNA (lncRNA) PART1 suppresses malignant progression of oral squamous cell carcinoma via miR-17-5p/SOCS6 axis.
    Du Y; Shuai Y; Wang H; Li H; Li Y
    Turk J Med Sci; 2023 Jun; 53(3):630-639. PubMed ID: 37476905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sulindac induces apoptosis and inhibits tumor growth in vivo in head and neck squamous cell carcinoma.
    Scheper MA; Nikitakis NG; Chaisuparat R; Montaner S; Sauk JJ
    Neoplasia; 2007 Mar; 9(3):192-9. PubMed ID: 17401459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The HDAC inhibitor, panobinostat, induces apoptosis by suppressing the expresssion of specificity protein 1 in oral squamous cell carcinoma.
    Jeon YJ; Ko SM; Cho JH; Chae JI; Shim JH
    Int J Mol Med; 2013 Oct; 32(4):860-6. PubMed ID: 23877235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. YM155 induces apoptosis through downregulation of specificity protein 1 and myeloid cell leukemia-1 in human oral cancer cell lines.
    Sachita K; Yu HJ; Yun JW; Lee JS; Cho SD
    J Oral Pathol Med; 2015 Nov; 44(10):785-91. PubMed ID: 25475012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the EZH2/miR-200 axis in STAT3-mediated OSCC invasion.
    Wang Y; Guo W; Li Z; Wu Y; Jing C; Ren Y; Zhao M; Kong L; Zhang C; Dong J; Shuang Y; Sun S; Chen J; Wu C; Qiao Y; Qu X; Wang X; Zhang L; Jin R; Zhou X
    Int J Oncol; 2018 Apr; 52(4):1149-1164. PubMed ID: 29532870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Interleukin-6 on STAT3-regulated signaling in oral cancer and as a prognosticator of patient survival.
    Wei LY; Lin HC; Tsai FC; Ko JY; Kok SH; Cheng SJ; Lee JJ; Chia JS
    Oral Oncol; 2022 Jan; 124():105665. PubMed ID: 34891076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Signal transducer and activator of transcription 3 pathway mediates genipin-induced apoptosis in U266 multiple myeloma cells.
    Lee JC; Ahn KS; Jeong SJ; Jung JH; Kwon TR; Rhee YH; Kim SH; Kim SY; Yoon HJ; Zhu S; Chen CY; Kim SH
    J Cell Biochem; 2011 Jun; 112(6):1552-62. PubMed ID: 21344490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. STAT3 and Its Targeting Inhibitors in Oral Squamous Cell Carcinoma.
    Jiang M; Li B
    Cells; 2022 Oct; 11(19):. PubMed ID: 36231093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ENO1 Binds to ApoC3 and Impairs the Proliferation of T Cells via IL-8/STAT3 Pathway in OSCC.
    Wang J; Man Q; Zhong N; Wang H; Zhang C; Li S; Bu L; Liu B
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promotion of ubiquitination-dependent survivin destruction contributes to xanthohumol-mediated tumor suppression and overcomes radioresistance in human oral squamous cell carcinoma.
    Li M; Gao F; Yu X; Zhao Q; Zhou L; Liu W; Li W
    J Exp Clin Cancer Res; 2020 May; 39(1):88. PubMed ID: 32410646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. STAT3 signal transduction through interleukin-22 in oral squamous cell carcinoma.
    Naher L; Kiyoshima T; Kobayashi I; Wada H; Nagata K; Fujiwara H; Ookuma YF; Ozeki S; Nakamura S; Sakai H
    Int J Oncol; 2012 Nov; 41(5):1577-86. PubMed ID: 22922995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The scorpion venom peptide BmKn2 induces apoptosis in cancerous but not in normal human oral cells.
    Satitmanwiwat S; Changsangfa C; Khanuengthong A; Promthep K; Roytrakul S; Arpornsuwan T; Saikhun K; Sritanaudomchai H
    Biomed Pharmacother; 2016 Dec; 84():1042-1050. PubMed ID: 27780132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of Histone Deacetylase Inhibitor Sensitivity in Combination with Cyclin-Dependent Kinase Inhibition for the Treatment of Oral Squamous Cell Carcinoma.
    Zhao B; Huang Z; Qin Z; Li Y; Wang T; Wang L; Zhou W; Yu C; Wang X; Yang S; Fan Y; Xiang R
    Cell Physiol Biochem; 2019; 53(1):141-156. PubMed ID: 31237760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glaucocalyxin A impairs tumor growth via amplification of the ATF4/CHOP/CHAC1 cascade in human oral squamous cell carcinoma.
    Wang X; He MJ; Chen XJ; Bai YT; Zhou G
    J Ethnopharmacol; 2022 May; 290():115100. PubMed ID: 35151835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro.
    Zhu WQ; Wang J; Guo XF; Liu Z; Dong WG
    World J Gastroenterol; 2016 Apr; 22(16):4149-59. PubMed ID: 27122665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curcumol Exerts Antitumor Effect via Inhibiting EGFR-Akt-Mcl-1 Signaling.
    Li XY; Gao F; Wang XC; Liu LL; Gan Y; Han SZ; Zhou L; Li W; Li M
    Am J Chin Med; 2023; 51(3):741-760. PubMed ID: 36869017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resveratrol inhibits STAT3 signaling pathway through the induction of SOCS-1: Role in apoptosis induction and radiosensitization in head and neck tumor cells.
    Baek SH; Ko JH; Lee H; Jung J; Kong M; Lee JW; Lee J; Chinnathambi A; Zayed ME; Alharbi SA; Lee SG; Shim BS; Sethi G; Kim SH; Yang WM; Um JY; Ahn KS
    Phytomedicine; 2016 May; 23(5):566-77. PubMed ID: 27064016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Licochalcone A, a natural chalconoid isolated from Glycyrrhiza inflata root, induces apoptosis via Sp1 and Sp1 regulatory proteins in oral squamous cell carcinoma.
    Cho JJ; Chae JI; Yoon G; Kim KH; Cho JH; Cho SS; Cho YS; Shim JH
    Int J Oncol; 2014 Aug; 45(2):667-74. PubMed ID: 24858379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Podophyllotoxin reduces the aggressiveness of human oral squamous cell carcinoma through myeloid cell leukemia‑1.
    Yu HJ; Shin JA; Choi SJ; Cho SD
    Int J Mol Med; 2023 Nov; 52(5):. PubMed ID: 37711052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.